Records containing: Spinal Muscular Atrophy Type 3
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-09Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
-
CLINICAL_TRIALS study record update · 2026-03-25A Phase 2, Double-Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Apitegromab in Subjects <2 Years Old With Spinal Muscular Atrophy (SMA)
-
CLINICAL_TRIALS study record update · 2026-03-18Identification of Gait-related Digital Biomarkers of Bone Health in Spinal Muscular Atrophy
-
CLINICAL_TRIALS study record update · 2026-03-16Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy
-
CLINICAL_TRIALS study record update · 2026-01-22Phase 3, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Apitegromab (SRK-015) in Patients With Later-Onset Spinal Muscular Atrophy Receiving Background Nusinersen or Risdiplam Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-26Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb Protocol
-
CLINICAL_TRIALS study record update · 2025-07-03A Multi-center, Open Label, Single-arm, Dose Ascending Clinical Trial for Evaluation of Safety and Efficacy of Gene Therapy Drug GC101 in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients
-
CLINICAL_TRIALS study record update · 2025-05-25An Open-Label, Multicenter, Extension Trial to Evaluate the Long-Term Safety and Efficacy of Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab
-
CLINICAL_TRIALS study record update · 2024-11-20A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA® (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
-
CLINICAL_TRIALS study record update · 2024-09-23Wearable Technology to Assess Gait Function in Spinal Muscle Atrophy and Duchenne Muscular Dystrophy
-
CLINICAL_TRIALS study record update · 2023-11-30Long Term Safety Study of Amifampridine Phosphate in Ambulatory Patients With Spinal Muscular Atrophy (SMA) Type 3
-
CLINICAL_TRIALS study record update · 2023-10-11Safety and Efficacy Study of Anti-cholinesterase Therapy on the Motor Functions in Patients With Spinal Muscular Atrophy Type 3.
-
CLINICAL_TRIALS study record update · 2023-10-10Pompe & Pain - Observational Study to Assess Musculoskeletal Pain in Late-onset Pompe Disease (LOPD)
-
CLINICAL_TRIALS study record update · 2023-09-28The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy"
-
CLINICAL_TRIALS study record update · 2022-11-17Phase 2 Active Treatment Study to Evaluate the Efficacy and Safety of SRK-015 in Patients With Later-Onset Spinal Muscular Atrophy (TOPAZ)
-
CLINICAL_TRIALS study record update · 2022-08-24Nociceptive Pain in Neuromuscular Disorders - Low Interventional Pilot Study to Assess Musculoskeletal Pain in Neuromuscular Disorders (NMD)
-
CLINICAL_TRIALS study record update · 2022-03-08Evaluation of Oxidative Capacity and Exercise Tolerance in Ambulatory Patients With Spinal Muscular Atrophy (SMA)
-
CLINICAL_TRIALS study record update · 2019-07-26Effect of Whole Body Vibration Therapy on Muscle Function, Gross Motor Function and Bone Mineral Density in Children With Spinal Muscular Atrophy - a Feasibility Study